Design, synthesis, estrogenic and antiestrogenic activities of some triarylpyrazole derivatives
- 166 Downloads
New triarylpyrazole derivatives, substituted with basic side chain, polar group or heterocyclic ring were designed and synthesized. Nineteen compounds were tested for their in vivo uterotrophic activity. Animals treated with compounds 9, 15a, 15c, 19a, 19f, 20a, and 21b showed pronounced increase in uterine weight. It is worth mentioning that compound 19f was more active than estradiol as an estrogenic compound as evidenced by the increased dry uterine weight. Additionally, compound 19a produced 128.25% increase in dry uterine weight relative to estradiol. On the other hand, eight compounds were screened for their in vivo antiuterotrophic activity. Animals treated with compounds 5e, 5f, 8, and 13b showed pronounced decrease in uterine weight. The highest antiuterotrophic effect was observed in mice receiving compound 13b, which was as potent as the positive control, tamoxifen as evident by the decrease in the uterine wet weight.
KeywordsSynthesis Pyrazoles Uterotrophic activity Antiuterotrophic activity
The authors are thankful to N.M. Andijani for her assistance in in vivo experiments.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Awazu Y, Mizutani A, Nagase Y, Tsuchiya S, Nakamura K, Kakoi Y, Kitahara O, Takeuchi T, Yamasaki S, Miyamoto N, Iwata H, Miki H, Imamura S, Hori A (2013) Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase. Cancer Sci 104:486–494CrossRefPubMedGoogle Scholar
- El-Tombary AA, Ismail KA, AboulWafa OM, Omar AMME, El-Reyini SH (1995) Synthesis of novel estradiol thiosemicarbazone derivatives as potential antiestrogens. Alex J Pharm Sci 9:147–152Google Scholar
- Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z (2009) Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms. J Med Chem 52:7544–7569CrossRefPubMedGoogle Scholar
- Kankanala J, Latham AM, Johnson AP, Homer-Vanniasinkam S, Fishwick CWG, Ponnambalam S (2012) A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis. Br J Pharmacol 166:737–748CrossRefPubMedPubMedCentralGoogle Scholar
- Magarian RA, Overacre LB, Singh S, Meyer KL (1994) The medicinal chemistry of nonsteroidal antiestrogens: a review. Curr Med Chem 1:61–104Google Scholar
- May M (1971) In: Turner R, Hebborn P (eds) Estrogenic and antiestrogenic agents in screening methods in pharmacology, vol 2, Ch. 6. Academic, New York, NY and London, 85–100Google Scholar
- Saripinar E, Guzel Y, Onal Z, Ilhan IO, Akcamur Y (2000) 4-(-4-methoxybenzoyl)-5-(-4-methoxyphenyl)-2,3-dihydro-2,3-furandione, it’s synthesis, thermolysis and Diels-Alder reactions with Schiff bases: Experimental data and calculations. J Chem Soc Pak 22:308–317Google Scholar